Human Epidermal Growth Factor 2 Low Breast Cancer
1 clinical trials · Condition
◉ Watch Human Epidermal Growth Factor 2 Low Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC (NCT06263543) | Reshma L. Mahtani, D.O. | 2024-06-17 |
Track Human Epidermal Growth Factor 2 Low Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.